Reviewer's report
Title:How do patients with inflammatory bowel disease want their biological
therapy administered?
Version: 1Date:2 July 2009
Reviewer: Laurent Peyrin-Biroulet
Reviewer's report:
The authors adequately and extensively responded to all my comments. I have
no further correction to suggest.
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a
statistician.
Declaration of competing interests:
I have received consulting fees from Abbott Laboratoires and UCB Pharma;
lecture fees from speaking at continuing medical education events from
Centocor; and grant support from UCB Pharma.
Reviewer's report
Title:How do patients with inflammatory bowel disease want their biological
therapy administered?
Version: 1Date:2 July 2009
Reviewer: Laurent Peyrin-Biroulet
Reviewer's report:
The authors adequately and extensively responded to all my comments. I have
no further correction to suggest.
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a
statistician.
Declaration of competing interests:
I have received consulting fees from Abbott Laboratoires and UCB Pharma;
lecture fees from speaking at continuing medical education events from
Centocor; and grant support from UCB Pharma.
Please review this paper.
user
Reviewer's report
Title:How do patients with inflammatory bowel disease want their biological
therapy administered?
Version: 1Date:2 July 2009
Reviewer: Laurent Peyrin-Biroulet
Reviewer's report:
The authors adequately and extensively responded to all my comments. I have
no further correction to suggest.
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a
statistician.
Declaration of competing interests:
I have received consulting fees from Abbott Laboratoires and UCB Pharma;
lecture fees from speaking at continuing medical education events from
Centocor; and grant support from UCB Pharma.
assistant